Search Results - "MIYAGI, MASAHIKO"

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study by Shigiyama, Fumika, Kumashiro, Naoki, Miyagi, Masahiko, Ikehara, Kayoko, Kanda, Eiichiro, Uchino, Hiroshi, Hirose, Takahisa

“…Recent studies reported that sodium glucose cotransporter 2 (SGLT2) inhibitors can potentially reduce the risk of cardiovascular mortality in patients with…”
Get full text

Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background by Yoshikawa, Fukumi, Kumashiro, Naoki, Shigiyama, Fumika, Miyagi, Masahiko, Ando, Yasuyo, Uchino, Hiroshi, Hirose, Takahisa

“…Aim Diabetes and aging are both well-established risk factors for insomnia. Therefore, we investigated the changes in subjective sleep quality in relation to…”
Get full text

SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes by Igarashi, Hiroyuki, Uchino, Hiroshi, Kanaguchi, Momoko, Hisanaga, Kaori, Sato, Genki, Yoshikawa, Fukumi, Furuta, Masashi, Washizawa, Naohiro, Usui, Shuki, Miyagi, Masahiko, Hirose, Takahisa

“…Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same…”
Get full text

Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function by Shigiyama, Fumika, Kumashiro, Naoki, Miyagi, Masahiko, Iga, Ryo, Kobayashi, Yuka, Kanda, Eiichiro, Uchino, Hiroshi, Hirose, Takahisa

“…Aims/Introduction The present multicenter, prospective, controlled, open and randomized three‐arm parallel study was designed to compare the effects of…”
Get full text

Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium–glucose cotransporter 2 inhibitor: A randomized, open‐label, prospective study by Kanazawa, Ken, Uchino, Hiroshi, Shigiyama, Fumika, Igarashi, Hiroyuki, Ikehara, Kayoko, Yoshikawa, Fukumi, Usui, Shuki, Miyagi, Masahiko, Yoshino, Hiroshi, Ando, Yasuyo, Kumashiro, Naoki, Hirose, Takahisa

“…Aims/Introduction Hyperglycemia impairs energy substrate oxidation as a result of glucotoxicity. We examined whether the reduction of plasma glucose using a…”
Get full text

Acute focal bacterial nephritis in an occupational allergy by Iga, Ryo, MD, Uchino, Hiroshi, Dr, Kanazawa, Ken, MD, Usui, Shuki, MD, Miyagi, Masahiko, MD, Kumashiro, Naoki, MD, Hirose, Takahisa, Prof

“…Laboratory findings showed a white-blood-cell count of 18 800 per [micro]L (normal value 4400-11 000 per [micro]L), C-reactive protein 16·3 mg/dL (<0·3 mg/dL),…”
Get full text

Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial by Yoshikawa, Fukumi, Uchino, Hiroshi, Nagashima, Tomoko, Usui, Shuki, Miyagi, Masahiko, Ando, Yasuyo, Hirose, Takahisa

“…Aims To improve glycemic variability (GV) is crucial in the management of multiple daily insulin (MDI) treatment in diabetes. To evaluate the GV improvement in…”
Get full text

Methanol-Assisted Catalysis by Chiral Tin Methoxides: An Alternative Asymmetric Aldol Process by Yanagisawa, Akira, Satou, Tomoya, Izumiseki, Atsuto, Tanaka, Youichi, Miyagi, Masahiko, Arai, Takayoshi, Yoshida, Kazuhiro

“…Opening a tin of catalysts: A catalytic enantioselective aldol reaction of alkenyl trichloroacetates with aldehydes was achieved using a (S)‐BINOL‐derived…”
Get full text

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm by Miyagi, Masahiko, Uchino, Hiroshi, Kumashiro, Naoki, Higa, Mariko, Shin, Koki, Sasamoto, Makiko, Kitazato, Hiroji, Tamaki, Motoyuki, Matsuhisa, Munehide, Hirose, Takahisa

“…Introduction It is unclear whether adding basal insulin or enhancing incretin signaling with a glucagon-like peptide-1 receptor agonist (GLP-1RA) is more…”
Get full text

Thyroid storm associated with Graves' disease covered by diabetic ketoacidosis: A case report by Osada, Erika, Hiroi, Naoki, Sue, Mariko, Masai, Natsumi, Iga, Ryo, Shigemitsu, Rika, Oka, Reiko, Miyagi, Masahiko, Iso, Kaoru, Kuboki, Koji, Yoshino, Gen

“…Thyroid storm is a condition in which multiple organ dysfunction results from failure of the compensatory mechanisms of the body owing to excessive thyroid…”
Get full text

Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia by Yoshikawa, Fukumi, Shigiyama, Fumika, Ando, Yasuyo, Miyagi, Masahiko, Uchino, Hiroshi, Hirose, Takahisa, Kumashiro, Naoki

“…•This is the first report on the chronic effects of suvorexant in type 2 diabetes patients.•Suvorexant improved sleep quality, abdominal circumference, and…”
Get full text

1865-P: SGLT2 Inhibition Compared with Iso-energetic/Low-Carbohydrate Diet Reprograms Systemic Substrate Oxidation in Type 2 Diabetes by IGARASHI, HIROYUKI, UCHINO, HIROSHI, FURUTA, MASASHI, MIYAGI, MASAHIKO, KUMASHIRO, NAOKI, HIROSE, TAKAHISA

“…Introduction: Pharmacologic inhibition of the renal sodium/glucose cotransporter-2 (SGLT2i) facilitates lipid oxidation. Iso-energetic/low-carbohydrate diet…”
Get full text

160-OR: Pretreatment Diabetes Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, in Cancer Patients with Immune-Check Point Inhibitor by HISANAGA, KAORI, UCHINO, HIROSHI, YOSHIKAWA, FUKUMI, SHIGIYAMA, FUMIKA, KUMASHIRO, NAOKI, HIROSE, TAKAHISA, ANDO, YASUYO, MIYAGI, MASAHIKO, ISOBE, KAZUTOSHI, HOMMA, SAKAE

“…Objective: Immune checkpoint inhibitors (ICIs) are novel anticancer agents, also generate peculiar dysimmune toxicities, related to immune-related adverse…”
Get full text

Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial by Iga, Ryo, Uchino, Hiroshi, Kanazawa, Ken, Usui, Shuki, Miyagi, Masahiko, Kumashiro, Naoki, Yoshino, Hiroshi, Ando, Yasuyo, Hirose, Takahisa

“…Introduction Optimal adjustment of basal insulin to overcome hypoglycemia and glycemic variability (GV) depends on its duration of action and peak-less…”
Get full text

Efficacy of intermittent empagliflozin supplementation on dietary self‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial by Yoshikawa, Fukumi, Kumashiro, Naoki, Shigiyama, Fumika, Uchino, Hiroshi, Ando, Yasuyo, Yoshino, Hiroshi, Miyagi, Masahiko, Ikehara, Kayoko, Hirose, Takahisa

“…Aims To explore the effects of intermittent use of empagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on dietary self‐management and glycaemic control…”
Get full text

Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study by Saito, Manabu, Uchino, Hiroshi, Iwata, Yoko, Fuchigami, Ayako, Sato, Genki, Yoshikawa, Fukumi, Miyagi, Masahiko, Miyazaki, Taito, Urita, Yoshihisa, Aoki, Kotaro, Ishii, Yoshikazu, Tateda, Kazuhiro, Hirose, Takahisa

“…The severe pathogenic ancient-type COVID-19, SARS-CoV-2/WA-1/2020 was the predominant gene variant in early 2020 in Japan, however, its transmissibility was…”
Get full text

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan by Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa

“…Although immune checkpoint inhibitors (ICIs) are promising in the treatment of advanced cancer, their use is associated with immune-related adverse events…”
Get full text

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum] by Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa

“…Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773-781. Page 775, left column, third paragraph, line 4, the text "(p<0.5)" should…”
Get full text

Beriberi heart failure caused by a retort pouch diet menu by Ishikawa, Yuichi, Miyagi, Masahiko, Matsumoto, Tomoko, Watanabe, Natsuko, Tojo, Yasushi, Hiroi, Naoki, Kuboki, Koji, Yoshino, Gen, Tsubota, Takaya, Yoshihara, Katsunori

Get more information